logo

For the Inventor, By the Inventor

South Plainfield, NJ, United States of America

Ptc Therapeutics, Inc.


USPTO Granted Patents = 183



Trademarks = 43

Forward Citations = 1,303

Loading Chart...
Loading Chart...

170 inventors (with patents filed for the assignee):

goldMedal Young-Choon Moon (51 out of 62 patents)

silverMedal Gary Mitchell Karp (49 out of 70 patents)

bronzeMedal Neil Gregory Almstead (39 out of 61 patents)

4.  Guangming Chen (38 out of 38 patents)

5.  Ellen Welch (35 out of 35 patents)

6.  Seongwoo Hwang (28 out of 28 patents)

7.  Nikolai A Naryshkin (26 out of 27 patents)

8.  Richard Gerald Wilde (21 out of 21 patents)

9.  Liangxian Cao (21 out of 21 patents)

10.  James Jan Takasugi (21 out of 24 patents)

11.  Jana Narasimhan (19 out of 19 patents)

12.  Peter Seongwoo Hwang (19 out of 19 patents)

13.  Hongyan Qi (19 out of 22 patents)

14.  Marla L Weetall (19 out of 20 patents)

15.  Nanjing Zhang (19 out of 20 patents)


Core Competencies:
Duchenne Muscular Dystrophy
Familial Dysautonomia
Huntington's Disease
Spinal Muscular Atrophy
Alpha-Synucleinopathies
RNA Splicing
Oxidative Stress Disorders
Mitochondrial Diseases
Pharmaceutical Compositions
Sepiapterin
Polymorphic Compounds
Cancer Treatments

183 patents:

1. 12458629 - Method for treating nonsense mutation mediated duchenne muscular dystrophy in pediatric patients (2025-11-04),
2. 12398140 - Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia (2025-08-26),
3. 12384797 - Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia (2025-08-12),
4. 12384789 - Compounds for treating Huntington's disease (2025-08-12),
5. 12329757 - Methods for increasing sepiapterin plasma exposure (2025-06-17),
6. 12325706 - Polymorphic form of sepiapterin (2025-06-10),
7. 12281083 - 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof (2025-04-21),
8. 12269829 - Polymorphs of sepiapterin and salts thereof (2025-04-08),
9. 12257252 - Compositions and methods for increasing tetrahydrobiopterin plasma exposure (2025-03-25),
10. 12213982 - Pharmaceutical compositions comprising sepiapterin and uses thereof (2025-02-04),
11. 12139499 - Heteroaryl compounds for treating Huntington's disease (2024-11-12),
12. 12103926 - Compounds for treating huntington's disease (2024-10-01),
13. 12023335 - Method for treating pancreatic cancer (2024-07-02),
14. 11938101 - Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide (2024-03-26),
15. 11858941 - Heterocyclic and heteroaryl compounds for treating Huntington's disease (2024-01-02),
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines for patients with rare diseases. Their focus lies in precision medicines targeting genetic disorders caused by RNA abnormalities. They are committed to improving the lives of patients by bringing advanced therapies to those in need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
183 Patents

#1 in South Plainfield, NJ

#100 in New Jersey

#2,141 in US

#4,430 in the World

...
South Plainfield, NJ, United States of America

Ptc Therapeutics, Inc.

Forward Citations = 1,303

170 inventors:

goldMedal Young-Choon Moon (51 out of 62 patents)

silverMedal Gary Mitchell Karp (49 out of 70 patents)

bronzeMedal Neil Gregory Almstead (39 out of 61 patents)

4.  Guangming Chen (38 out of 38 patents)

5.  Ellen Welch (35 out of 35 patents)

Please report any incorrect information to support@idiyas.com
Loading…